Product Information
RETIN-A 0.1% CREAM is a brand product labeled by Bausch Health US LLC, priced at $0.9594 per GM under NDC 00187516445. Its NADAC has been published 320 times since Aug 21, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/g
Manufacturer
Bausch Health US LLCNDC
00187516445
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
TRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA017340FDA Approved
Before 1982
TE Code
AB
On Market Since
4/30/1973
Pharmacological Classes
Price Statistics
The NADAC for RETIN-A 0.1% CREAM has been published 320 times since Aug 21, 2019, and over the history we have for it it has declined 52.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9594 per GM |
|---|---|
| All-time high | $2.0203 (Oct 2, 2019) |
| All-time low | $0.9587 (Jun 19, 2024) |
| Median price | $1.6786 |
| Average price | $1.3838 |
| Largest weekly change | -43.2% (Feb 22, 2023) |
| Weeks tracked | 320 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-0.4%
5Y
-43.3%
All
-52.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RETIN-A 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for RETIN-A 0.1% CREAM, manufactured by Bausch Health US LLC, is $0.9594 per GM (NDC 00187516445), effective Oct 1, 2025.
How has the price of RETIN-A 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for RETIN-A 0.1% CREAM has declined 52.5%. It has been tracked across 320 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for RETIN-A 0.1% CREAM?
Since Aug 21, 2019, the NADAC for RETIN-A 0.1% CREAM has ranged from a low of $0.9587 (Jun 19, 2024) to a high of $2.0203 (Oct 2, 2019), with a median of $1.6786 per GM.
Are there cheaper alternatives to RETIN-A 0.1% CREAM?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRETINOIN 0.1% CREAM, is $0.7701 per GM — about 20% below RETIN-A 0.1% CREAM.
Who manufactures RETIN-A 0.1% CREAM?
RETIN-A 0.1% CREAM (NDC 00187516445) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.